Home › Osteosarcoma › Tennessee › Nashville
Osteosarcoma clinical trials in Nashville, TN
3 studies for Osteosarcoma are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RecruitingPhase 3
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
Osteosarcoma trials in other cities
- Memphis, TN10 studies
- Atlanta, GA10 studies
- St. Louis, MO10 studies
- Boston, MA9 studies
- Mountain View, CA8 studies
- Chicago, IL7 studies
- Los Angeles, CA7 studies
- Birmingham, AL7 studies
- Houston, TX7 studies
- Tampa, FL6 studies
- New York City, NY6 studies
- Washington, DC6 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer80 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.